Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
Host Transcriptome and Microbiota Signatures Prior to Immunization Profile Vaccine Humoral Responsiveness.
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.
T cells from ART-suppressed individuals can originate from biologically competent proviruses.
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
Pitting of malaria parasites in microfluidic devices mimicking spleen interendothelial slits.